These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3871854)

  • 21. Kinetics of drug action in disease states. XIX. Effect of experimental liver disease on the neurotoxicity of theophylline in rats.
    Ramzan IM; Yasuhara M; Levy G
    J Pharmacol Exp Ther; 1987 Apr; 241(1):236-8. PubMed ID: 3494838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of drug action in disease states. XLIII: Potentiating effect of L-tryptophan on the hypnotic action of phenobarbital and ethanol in rats.
    Wilson TC; Levy G
    J Pharm Sci; 1994 Oct; 83(10):1433-6. PubMed ID: 7884665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of drug action in disease states. XXV. Effect of experimental hypovolemia on the pharmacodynamics and pharmacokinetics of desmethyldiazepam.
    Klockowski PM; Levy G
    J Pharmacol Exp Ther; 1988 May; 245(2):508-12. PubMed ID: 2835474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats.
    Lin JH; Levy G
    J Pharmacol Exp Ther; 1982 Apr; 221(1):80-4. PubMed ID: 7062293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of drug action in disease states XI: effect of nicotine on the pharmacodynamics and pharmacokinetics of phenobarbital and ethanol in rats.
    Hisaoka M; Levy G
    J Pharm Sci; 1985 Apr; 74(4):412-5. PubMed ID: 3999001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of drug action in disease states. XXXIII: Disparate effects of pentylenetetrazol in rats as a function of renal disease model and pharmacologic endpoint.
    Ramzan I; Levy G
    J Pharm Sci; 1989 Feb; 78(2):142-5. PubMed ID: 2715936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of age on the pharmacodynamics of phenobarbital and ethanol in rats.
    Wanwimolruk S; Levy G
    J Pharm Sci; 1987 Jul; 76(7):503-7. PubMed ID: 3668809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of 35S-furosemide in experimental kidney failure in the rat].
    Mansouri M; Legheand J; Sassard J
    J Pharmacol; 1984; 15(1):79-86. PubMed ID: 6717029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barbiturate anesthesia and alcohol tolerance in a rat model.
    Curran MA; Newman LM; Becker GL
    Anesth Analg; 1988 Sep; 67(9):868-71. PubMed ID: 3414998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal activation in the CNS during different forms of acute renal failure in rats.
    Palkovits M; Sebekova K; Gallatz K; Boor P; Sebekova K; Klassen A; Bahner U; Heidland A
    Neuroscience; 2009 Mar; 159(2):862-82. PubMed ID: 19174183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of metoclopramide in rats with experimental renal and hepatic dysfunction.
    Tam YK; Axelson JE; McErlane B; Kapil RP; Riggs KW; Ongley R; Price JD
    J Pharmacol Exp Ther; 1981 Oct; 219(1):141-6. PubMed ID: 7288603
    [No Abstract]   [Full Text] [Related]  

  • 37. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
    Hoffman A; Levy G
    Pharm Res; 1990 Mar; 7(3):242-6. PubMed ID: 2339096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of brain ethanol metabolism to the hypnotic effect of ethanol. I: Studies in outbred animals.
    Zimatkin SM; Liopo AV; Slychenkov VS; Deitrich RA
    Alcohol Clin Exp Res; 2001 Jul; 25(7):976-81. PubMed ID: 11505021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increases in brain tryptophan concentration in stressed rats following ethanol administration.
    Dawood S; Bano S
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):674-8. PubMed ID: 16300698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.